Results for tag: "Chronic Venous Ulceration Drug"

Chronic Venous Ulceration (CVU) is a type of cardiovascular disease that affects the veins in the legs. It is caused by poor circulation and can lead to ulcers, pain, and swelling. Treatment for CVU includes lifestyle changes, compression therapy, and medications. Drug therapy is used to reduce inflammation, improve circulation, and promote healing. Commonly prescribed drugs include anticoagulants, anti-inflammatory drugs, and vasodilators. The CVU drug market is a rapidly growing segment of the cardiovascular drug market. It is driven by the increasing prevalence of CVU, the development of new drugs, and the growing demand for better treatments. The market is expected to continue to grow in the coming years as more effective treatments become available. Some of the major companies in the CVU drug market include Pfizer, Merck, Sanofi, Novartis, and Bayer. Show Less Read more